TalkMed Group Valuation

Q: What is the Fair Price of 5G3 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

5G3 (SGD0.44) is trading below our estimate of [[fair value]] (SGD0.44)

Is 5G3 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 5G3 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 5G3 (SGD0.44) is trading below our estimate of fair value (SGD0.44)

Significantly Below Fair Value: 5G3 is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 5G3?

Key metric: As 5G3 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 5G3. This is calculated by dividing 5G3's market cap by their current earnings.
What is 5G3's PE Ratio?
PE Ratio	20.6x
Earnings	S$28.30m
Market Cap	S$584.17m

5G3 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	6.3x
Enterprise Value/EBITDA	14.9x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 5G3's PE Ratio compare to its peers?

The above table shows the PE ratio for 5G3 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	22.3x
QC7 Q & M Dental Group (Singapore)	16.9x	5.6%	S$270.4m
5NG Healthway Medical	24.5x	n/a	S$213.2m
1B1 HC Surgical Specialists	11x	n/a	S$42.3m
MIJ Alliance Healthcare Group	36.9x	n/a	S$26.6m
5G3 TalkMed Group	20.6x	n/a	S$584.2m

Price-To-Earnings vs Peers: 5G3 is good value based on its Price-To-Earnings Ratio (20.6x) compared to the peer average (21.6x).

Price to Earnings Ratio vs Industry

How does 5G3's PE Ratio compare vs other companies in the Asian Healthcare Industry?

2 Companies	Price / Earnings	Estimated Growth	Market Cap

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 5G3 is good value based on its Price-To-Earnings Ratio (20.6x) compared to the Asian Healthcare industry average (20.8x).

Price to Earnings Ratio vs Fair Ratio

What is 5G3's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

5G3 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	20.6x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 5G3's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

IHH Healthcare Berhad

RM 63.4b

An investment holding company, provides healthcare services in Malaysia, Singapore, Turkey, India, China, Japan, Turkey, Europe, and internationally.

Q0F

RM 2.15

-1.4%

29.5%

Yunnan Energy International

HK$209.3m

An investment holding company, distributes analytical and laboratory instruments, and life science equipment in the People’s Republic of China, Hong Kong, Macau, Oceania, Asia, and internationally.

T43

HK$0.075

n/a

Econ Healthcare (Asia)

S$58.5m

An investment holding company, engages in the operation of medicare centers and nursing homes for eldercare in Singapore, Malaysia, and China.

EHG

S$0.22

4.8%

10.0%